Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-09-15

FDA Approved: ONDANSETRON HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

The FDA approved a supplemental application for ondansetron hydrochloride from Hikma Pharmaceuticals USA Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ondansetron hydrochloride (ondansetron hydrochloride)

Snippet

SUPPL AP for ONDANSETRON HYDROCHLORIDE (ONDANSETRON HYDROCHLORIDE)